paragraph_index int64 | sec string | p_has_citation int64 | cites string | citeids list | pmid int64 | cited_id string | sentences string | all_sent_cites list | sent_len int64 | sentence_batch_index int64 | sent_has_citation float64 | qc_fail bool | cited_sentence string | cites_in_sentence list | cln_sentence string | is_cap bool | is_alpha bool | ends_wp bool | cit_qc bool | lgtm bool | __index_level_0__ int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | The Mg2+-bound dNTP substrate is proposed to enter the active site first, and is initially positioned by the interaction of its phosphate moiety with the enzyme (51). | [
"51",
"14"
] | 166 | 11,100 | 1 | false | The Mg2+-bound dNTP substrate is proposed to enter the active site first, and is initially positioned by the interaction of its phosphate moiety with the enzyme. | [
"51"
] | The Mg2+-bound dNTP substrate is proposed to enter the active site first, and is initially positioned by the interaction of its phosphate moiety with the enzyme. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | The Mg2+ ion coordinates Asp190 and 192. | [
"51",
"14"
] | 40 | 11,101 | 0 | false | The Mg2+ ion coordinates Asp190 and 192. | [] | The Mg2+ ion coordinates Asp190 and 192. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | Upon binding of the Mg2+–dNTP, the polymerase is thought to assume a closed conformation. | [
"51",
"14"
] | 89 | 11,102 | 0 | false | Upon binding of the Mg2+–dNTP, the polymerase is thought to assume a closed conformation. | [] | Upon binding of the Mg2+–dNTP, the polymerase is thought to assume a closed conformation. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | The catalytic Mg2+ then binds and coordinates both Asp256 and Asp192. | [
"51",
"14"
] | 69 | 11,103 | 0 | false | The catalytic Mg2+ then binds and coordinates both Asp256 and Asp192. | [] | The catalytic Mg2+ then binds and coordinates both Asp256 and Asp192. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | It also coordinates with the 3′ OH of the primer strand. | [
"51",
"14"
] | 56 | 11,104 | 0 | false | It also coordinates with the 3′ OH of the primer strand. | [] | It also coordinates with the 3′ OH of the primer strand. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 14 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | After binding of the catalytic Mg2+, phosphodiester bond formation is observed in crystals (14). | [
"51",
"14"
] | 96 | 11,105 | 1 | false | After binding of the catalytic Mg2+, phosphodiester bond formation is observed in crystals. | [
"14"
] | After binding of the catalytic Mg2+, phosphodiester bond formation is observed in crystals. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | Asp256, which is part of a β strand, is just three amino acid residues away from loop II and could be affected by geometric strain or movements of the five residue loop variants. | [
"51",
"14"
] | 178 | 11,106 | 0 | false | Asp256, which is part of a β strand, is just three amino acid residues away from loop II and could be affected by geometric strain or movements of the five residue loop variants. | [] | Asp256, which is part of a β strand, is just three amino acid residues away from loop II and could be affected by geometric strain or movements of the five residue loop variants. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | Thus, if a five-member loop assumes an aberrant structure or lacks proper dynamic movement, it could result in destabilization of Asp256. | [
"51",
"14"
] | 137 | 11,107 | 0 | false | Thus, if a five-member loop assumes an aberrant structure or lacks proper dynamic movement, it could result in destabilization of Asp256. | [] | Thus, if a five-member loop assumes an aberrant structure or lacks proper dynamic movement, it could result in destabilization of Asp256. | true | true | true | true | true | 1,776 |
7 | DISCUSSION | 1 | 51 | [
"B51",
"B14"
] | 17,439,962 | pmid-9920940|pmid-10585471|pmid-14563842|pmid-10585471|pmid-14563842|pmid-15794655|pmid-11330999 | This could lead to slightly altered positioning of the 3′ terminus of the primer or the incoming dNTP and result in misincorporation. | [
"51",
"14"
] | 133 | 11,108 | 0 | false | This could lead to slightly altered positioning of the 3′ terminus of the primer or the incoming dNTP and result in misincorporation. | [] | This could lead to slightly altered positioning of the 3′ terminus of the primer or the incoming dNTP and result in misincorporation. | true | true | true | true | true | 1,776 |
8 | DISCUSSION | 1 | 5 | [
"B5"
] | 17,439,962 | pmid-8538772 | In our BER assay, all of the loop II variants were able to participate in the reaction that led to the finished ligation product, including loops consisting of 0–2 amino acid residues. | [
"5"
] | 184 | 11,109 | 0 | false | In our BER assay, all of the loop II variants were able to participate in the reaction that led to the finished ligation product, including loops consisting of 0–2 amino acid residues. | [] | In our BER assay, all of the loop II variants were able to participate in the reaction that led to the finished ligation product, including loops consisting of 0–2 amino acid residues. | true | true | true | true | true | 1,777 |
8 | DISCUSSION | 1 | 5 | [
"B5"
] | 17,439,962 | pmid-8538772 | This suggests that pol β does not have to possess robust polymerase activity to participate in BER, and supports the idea that the dRP lyase activity of pol β is critical for repair (5). | [
"5"
] | 186 | 11,110 | 1 | false | This suggests that pol β does not have to possess robust polymerase activity to participate in BER, and supports the idea that the dRP lyase activity of pol β is critical for repair. | [
"5"
] | This suggests that pol β does not have to possess robust polymerase activity to participate in BER, and supports the idea that the dRP lyase activity of pol β is critical for repair. | true | true | true | true | true | 1,777 |
8 | DISCUSSION | 1 | 5 | [
"B5"
] | 17,439,962 | pmid-8538772 | However, we have recently found that a pol β variant that possesses dRP lyase activity but no polymerase activity does not support BER in vitro (Lang et al., submitted for publication), suggesting that both the dRP lyase and polymerase activities of pol β are critical for repair. | [
"5"
] | 280 | 11,111 | 0 | false | However, we have recently found that a pol β variant that possesses dRP lyase activity but no polymerase activity does not support BER in vitro (Lang et al., submitted for publication), suggesting that both the dRP lyase and polymerase activities of pol β are critical for repair. | [] | However, we have recently found that a pol β variant that possesses dRP lyase activity but no polymerase activity does not support BER in vitro (Lang et al., submitted for publication), suggesting that both the dRP lyase and polymerase activities of pol β are critical for repair. | true | true | true | true | true | 1,777 |
8 | DISCUSSION | 1 | 5 | [
"B5"
] | 17,439,962 | pmid-8538772 | The demonstration that even the Loopless variant of pol β participates in BER also suggests that loop II is unlikely to be important for interactions with other proteins that are important for BER. | [
"5"
] | 197 | 11,112 | 0 | false | The demonstration that even the Loopless variant of pol β participates in BER also suggests that loop II is unlikely to be important for interactions with other proteins that are important for BER. | [] | The demonstration that even the Loopless variant of pol β participates in BER also suggests that loop II is unlikely to be important for interactions with other proteins that are important for BER. | true | true | true | true | true | 1,777 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | The Rat Genome Database (RGD, ) is the model organism database for the laboratory rat, Rattus norvegicus. | [
"1",
"2",
"3",
"4"
] | 105 | 11,113 | 0 | false | The Rat Genome Database (RGD, ) is the model organism database for the laboratory rat, Rattus norvegicus. | [] | The Rat Genome Database (RGD, ) is the model organism database for the laboratory rat, Rattus norvegicus. | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | The primary goal of the database is to provide convenient access to high quality data about the genes and genome of the Rat and to support the goals of researchers using the rat as a genetic and genomic model [see (1) for a review of the impact of genomics in rat research]. | [
"1",
"2",
"3",
"4"
] | 274 | 11,114 | 0 | false | The primary goal of the database is to provide convenient access to high quality data about the genes and genome of the Rat and to support the goals of researchers using the rat as a genetic and genomic model. | [
"see (1) for a review of the impact of genomics in rat research"
] | The primary goal of the database is to provide convenient access to high quality data about the genes and genome of the Rat and to support the goals of researchers using the rat as a genetic and genomic model. | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | In pursuit of these goals we curate a variety of other relevant information such as mapping information (genetic maps, radiation hybrid maps and most recently the genome assembly), quantitative trait loci (regions of the rat genome believed to contain a gene or genes related to a particular phenotype or trait), rat str... | [
"1",
"2",
"3",
"4"
] | 432 | 11,115 | 0 | false | In pursuit of these goals we curate a variety of other relevant information such as mapping information (genetic maps, radiation hybrid maps and most recently the genome assembly), quantitative trait loci (regions of the rat genome believed to contain a gene or genes related to a particular phenotype or trait), rat str... | [] | In pursuit of these goals we curate a variety of other relevant information such as mapping information (genetic maps, radiation hybrid maps and most recently the genome assembly), quantitative trait loci (regions of the rat genome believed to contain a gene or genes related to a particular phenotype or trait), rat str... | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | This data is acquired from a variety of sources: the literature, other scientific databases and through bioinformatic analyses performed locally. | [
"1",
"2",
"3",
"4"
] | 145 | 11,116 | 0 | false | This data is acquired from a variety of sources: the literature, other scientific databases and through bioinformatic analyses performed locally. | [] | This data is acquired from a variety of sources: the literature, other scientific databases and through bioinformatic analyses performed locally. | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | The public website provides convenient access to this data through search tools, web page reports and more specialized bioinformatics tools that can be used to do novel analyses directly online. | [
"1",
"2",
"3",
"4"
] | 194 | 11,117 | 0 | false | The public website provides convenient access to this data through search tools, web page reports and more specialized bioinformatics tools that can be used to do novel analyses directly online. | [] | The public website provides convenient access to this data through search tools, web page reports and more specialized bioinformatics tools that can be used to do novel analyses directly online. | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 2 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | Data curated at RGD is also available through other global genomics resources such as NCBI/Entrez Genes (2) and on the Ensembl (3) and UCSC genome browsers (4). | [
"1",
"2",
"3",
"4"
] | 160 | 11,118 | 1 | false | Data curated at RGD is also available through other global genomics resources such as NCBI/Entrez Genes and on the Ensembl and UCSC genome browsers. | [
"2",
"3",
"4"
] | Data curated at RGD is also available through other global genomics resources such as NCBI/Entrez Genes and on the Ensembl and UCSC genome browsers. | true | true | true | true | true | 1,778 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b3",
"b4"
] | 17,151,068 | pmid-16339370|pmid-15608257|pmid-16381931|pmid-16381938 | In addition, our data is freely available as FTP files to enable anyone to use it in their research or analysis. | [
"1",
"2",
"3",
"4"
] | 112 | 11,119 | 0 | false | In addition, our data is freely available as FTP files to enable anyone to use it in their research or analysis. | [] | In addition, our data is freely available as FTP files to enable anyone to use it in their research or analysis. | true | true | true | true | true | 1,778 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | A resource like RGD evolves in parallel with its community and for a model organism database, this community includes the researchers using that model organism and also the broader genomics and bioinformatics communities wishing to access and use this data. | [
"5",
"6",
"7",
"6"
] | 257 | 11,120 | 0 | false | A resource like RGD evolves in parallel with its community and for a model organism database, this community includes the researchers using that model organism and also the broader genomics and bioinformatics communities wishing to access and use this data. | [] | A resource like RGD evolves in parallel with its community and for a model organism database, this community includes the researchers using that model organism and also the broader genomics and bioinformatics communities wishing to access and use this data. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | One of the most significant trends in recent years that has greatly influenced the database has been the use of biological ontologies, of which the Gene Ontology (5) is perhaps the most well known. | [
"5",
"6",
"7",
"6"
] | 197 | 11,121 | 1 | false | One of the most significant trends in recent years that has greatly influenced the database has been the use of biological ontologies, of which the Gene Ontology is perhaps the most well known. | [
"5"
] | One of the most significant trends in recent years that has greatly influenced the database has been the use of biological ontologies, of which the Gene Ontology is perhaps the most well known. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | By providing a set of standardized terms, definitions and relationships between the terms, ontologies are very convenient for researchers as a way to consistently annotate and categorize data. | [
"5",
"6",
"7",
"6"
] | 192 | 11,122 | 0 | false | By providing a set of standardized terms, definitions and relationships between the terms, ontologies are very convenient for researchers as a way to consistently annotate and categorize data. | [] | By providing a set of standardized terms, definitions and relationships between the terms, ontologies are very convenient for researchers as a way to consistently annotate and categorize data. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | For the bioinformatics community they are emerging as a way to standardize data representations, enabling cross-organism data mining and analysis and have opened up avenues for novel data representation and integration (6,7). | [
"5",
"6",
"7",
"6"
] | 225 | 11,123 | 0 | false | For the bioinformatics community they are emerging as a way to standardize data representations, enabling cross-organism data mining and analysis and have opened up avenues for novel data representation and integration. | [
"6,7"
] | For the bioinformatics community they are emerging as a way to standardize data representations, enabling cross-organism data mining and analysis and have opened up avenues for novel data representation and integration. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 6 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | Another significant trend facing anyone using online resources and one that is particularly acute for modern biologists is the massive increase in information available (6). | [
"5",
"6",
"7",
"6"
] | 173 | 11,124 | 1 | false | Another significant trend facing anyone using online resources and one that is particularly acute for modern biologists is the massive increase in information available. | [
"6"
] | Another significant trend facing anyone using online resources and one that is particularly acute for modern biologists is the massive increase in information available. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | The problem ranges from not finding enough data to finding too much and being unable to efficiently comprehend what is available. | [
"5",
"6",
"7",
"6"
] | 129 | 11,125 | 0 | false | The problem ranges from not finding enough data to finding too much and being unable to efficiently comprehend what is available. | [] | The problem ranges from not finding enough data to finding too much and being unable to efficiently comprehend what is available. | true | true | true | true | true | 1,779 |
1 | INTRODUCTION | 1 | 5 | [
"b5",
"b6",
"b7",
"b6"
] | 17,151,068 | pmid-10802651|pmid-16564748|pmid-16899495|pmid-16564748 | Driven by the needs of our community we have been exploring ways to utilize the descriptive power of our ontology annotations combined with innovative visualization tools and web designs to begin to address this problem. | [
"5",
"6",
"7",
"6"
] | 220 | 11,126 | 0 | false | Driven by the needs of our community we have been exploring ways to utilize the descriptive power of our ontology annotations combined with innovative visualization tools and web designs to begin to address this problem. | [] | Driven by the needs of our community we have been exploring ways to utilize the descriptive power of our ontology annotations combined with innovative visualization tools and web designs to begin to address this problem. | true | true | true | true | true | 1,779 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | cis-Diamminedichloroplatinum(II) (cisplatin) (Figure 1A) has been widely used in chemotherapy for almost 30 years. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 114 | 11,127 | 0 | false | cis-Diamminedichloroplatinum(II) (cisplatin) has been widely used in chemotherapy for almost 30 years. | [
"Figure 1A"
] | cis-Diamminedichloroplatinum(II) (cisplatin) has been widely used in chemotherapy for almost 30 years. | false | true | true | true | false | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Hence, mechanisms underlying biological effects of this purely inorganic, simple, but outstanding compound have been intensively examined. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 138 | 11,128 | 0 | false | Hence, mechanisms underlying biological effects of this purely inorganic, simple, but outstanding compound have been intensively examined. | [] | Hence, mechanisms underlying biological effects of this purely inorganic, simple, but outstanding compound have been intensively examined. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | In spite of this intensive research lasting more than three decades, many important details of the mechanism of anticancer effects of cisplatin have not been so far clarified. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 175 | 11,129 | 0 | false | In spite of this intensive research lasting more than three decades, many important details of the mechanism of anticancer effects of cisplatin have not been so far clarified. | [] | In spite of this intensive research lasting more than three decades, many important details of the mechanism of anticancer effects of cisplatin have not been so far clarified. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | It is generally accepted that the major pharmacological target of cisplatin and other platinum anticancer compounds is DNA (1) and that the cytotoxicity of platinum compounds is thought to be determined primarily by their DNA adducts (2). | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 238 | 11,130 | 1 | false | It is generally accepted that the major pharmacological target of cisplatin and other platinum anticancer compounds is DNA and that the cytotoxicity of platinum compounds is thought to be determined primarily by their DNA adducts. | [
"1",
"2"
] | It is generally accepted that the major pharmacological target of cisplatin and other platinum anticancer compounds is DNA and that the cytotoxicity of platinum compounds is thought to be determined primarily by their DNA adducts. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 3 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Numerous studies show that cisplatin forms in DNA ∼90% intrastrand cross-links (CLs) between neighboring purine bases (1,2-GG or 1,2-AG intrastrand CLs) and remaining lesions are intrastrand CLs between purine bases separated by a third base, interstrand CLs and monofunctional adducts (3) Structures, other physical pro... | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 474 | 11,131 | 1 | false | Numerous studies show that cisplatin forms in DNA ∼90% intrastrand cross-links (CLs) between neighboring purine bases and remaining lesions are intrastrand CLs between purine bases separated by a third base, interstrand CLs and monofunctional adducts Structures, other physical properties of these adducts and their reco... | [
"1,2-GG or 1,2-AG intrastrand CLs",
"3",
"4–6"
] | Numerous studies show that cisplatin forms in DNA ∼90% intrastrand cross-links (CLs) between neighboring purine bases and remaining lesions are intrastrand CLs between purine bases separated by a third base, interstrand CLs and monofunctional adducts Structures, other physical properties of these adducts and their reco... | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Importantly, some studies indicate that cisplatin forms besides these DNA adducts also ternary DNA–platinum–protein CLs (DPCLs) | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 127 | 11,132 | 0 | false | Importantly, some studies indicate that cisplatin forms besides these DNA adducts also ternary DNA–platinum–protein CLs (DPCLs) | [] | Importantly, some studies indicate that cisplatin forms besides these DNA adducts also ternary DNA–platinum–protein CLs (DPCLs) | true | true | false | true | false | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | [see Wozniak and Walter (7) for review]. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 40 | 11,133 | 0 | false | . | [
"see Wozniak and Walter (7) for review"
] | . | false | false | true | true | false | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | For instance, cisplatin has been reported to cross-link chromosomal proteins, including histones or cytokeratins, to DNA (8,9). | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 127 | 11,134 | 0 | false | For instance, cisplatin has been reported to cross-link chromosomal proteins, including histones or cytokeratins, to DNA. | [
"8,9"
] | For instance, cisplatin has been reported to cross-link chromosomal proteins, including histones or cytokeratins, to DNA. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 10 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Interestingly, DPCLs have been shown to play an important role in cytotoxicity within the clinical dosage range of cisplatin (10), but frequency of these ternary complexes depends on the cell type (11) and time of the treatment (7,9). | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 234 | 11,135 | 1 | false | Interestingly, DPCLs have been shown to play an important role in cytotoxicity within the clinical dosage range of cisplatin, but frequency of these ternary complexes depends on the cell type and time of the treatment. | [
"10",
"11",
"7,9"
] | Interestingly, DPCLs have been shown to play an important role in cytotoxicity within the clinical dosage range of cisplatin, but frequency of these ternary complexes depends on the cell type and time of the treatment. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Figure 1.Structures of platinum compounds and sequences of the synthetic oligodeoxyribonucleotides with their abbreviations. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 124 | 11,136 | 0 | false | Figure 1.Structures of platinum compounds and sequences of the synthetic oligodeoxyribonucleotides with their abbreviations. | [] | Figure 1.Structures of platinum compounds and sequences of the synthetic oligodeoxyribonucleotides with their abbreviations. | true | true | true | true | true | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | (A) Structures: a, cisplatin; b, transplatin. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 45 | 11,137 | 0 | false | (A) Structures: a, cisplatin; b, transplatin. | [] | (A) Structures: a, cisplatin; b, transplatin. | false | false | true | true | false | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | (B) Sequences: the top and bottom strands of each pair in the figure are designated ‘top’ and ‘bottom’, respectively, throughout. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 129 | 11,138 | 0 | false | (B) Sequences: the top and bottom strands of each pair in the figure are designated ‘top’ and ‘bottom’, respectively, throughout. | [] | (B) Sequences: the top and bottom strands of each pair in the figure are designated ‘top’ and ‘bottom’, respectively, throughout. | false | false | true | true | false | 1,780 |
0 | INTRODUCTION | 1 | 1 | [
"B1",
"B2",
"B3",
"B4 B5 B6",
"B7",
"B8",
"B9",
"B10",
"B11",
"B7",
"B9"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | The boldface letters in the top strands of the duplexes TGGT(20), TGTGT(20), TGCT(20), TGT(20) and TGGT(NER) indicate the platinated residues. | [
"1",
"2",
"3",
"4–6",
"7",
"8",
"9",
"10",
"11",
"7",
"9"
] | 142 | 11,139 | 0 | false | The boldface letters in the top strands of the duplexes TGGT, TGTGT, TGCT, TGT and TGGT(NER) indicate the platinated residues. | [
"20",
"20",
"20",
"20"
] | The boldface letters in the top strands of the duplexes TGGT, TGTGT, TGCT, TGT and TGGT(NER) indicate the platinated residues. | true | true | true | true | true | 1,780 |
1 | INTRODUCTION | 0 | null | null | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | Structures of platinum compounds and sequences of the synthetic oligodeoxyribonucleotides with their abbreviations. | null | 115 | 11,140 | 0 | false | null | null | Structures of platinum compounds and sequences of the synthetic oligodeoxyribonucleotides with their abbreviations. | true | true | true | true | true | 1,781 |
1 | INTRODUCTION | 0 | null | null | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | (A) Structures: a, cisplatin; b, transplatin. | null | 45 | 11,141 | 0 | false | null | null | (A) Structures: a, cisplatin; b, transplatin. | false | false | true | true | false | 1,781 |
1 | INTRODUCTION | 0 | null | null | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | (B) Sequences: the top and bottom strands of each pair in the figure are designated ‘top’ and ‘bottom’, respectively, throughout. | null | 129 | 11,142 | 0 | false | null | null | (B) Sequences: the top and bottom strands of each pair in the figure are designated ‘top’ and ‘bottom’, respectively, throughout. | false | false | true | true | false | 1,781 |
1 | INTRODUCTION | 0 | null | null | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | The boldface letters in the top strands of the duplexes TGGT(20), TGTGT(20), TGCT(20), TGT(20) and TGGT(NER) indicate the platinated residues. | null | 142 | 11,143 | 0 | false | null | null | The boldface letters in the top strands of the duplexes TGGT(20), TGTGT(20), TGCT(20), TGT(20) and TGGT(NER) indicate the platinated residues. | true | true | true | true | true | 1,781 |
2 | INTRODUCTION | 1 | 4 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | Several models of the mechanism underlying antitumor effects of cisplatin have been already presented, but several have not taken into account the existence and specific properties of the DPCLs formed by this drug (4,12,13). | [
"4",
"12",
"13",
"14",
"15"
] | 224 | 11,144 | 0 | false | Several models of the mechanism underlying antitumor effects of cisplatin have been already presented, but several have not taken into account the existence and specific properties of the DPCLs formed by this drug. | [
"4,12,13"
] | Several models of the mechanism underlying antitumor effects of cisplatin have been already presented, but several have not taken into account the existence and specific properties of the DPCLs formed by this drug. | true | true | true | true | true | 1,782 |
2 | INTRODUCTION | 1 | 4 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | Nevertheless, a few studies have been performed. | [
"4",
"12",
"13",
"14",
"15"
] | 48 | 11,145 | 0 | false | Nevertheless, a few studies have been performed. | [] | Nevertheless, a few studies have been performed. | true | true | true | true | true | 1,782 |
2 | INTRODUCTION | 1 | 14 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | For instance, it has been shown that the participation of nuclear proteins in DPCLs induced by cisplatin can disturb the nuclear metabolism and the spatial organization of chromatin (14). | [
"4",
"12",
"13",
"14",
"15"
] | 187 | 11,146 | 1 | false | For instance, it has been shown that the participation of nuclear proteins in DPCLs induced by cisplatin can disturb the nuclear metabolism and the spatial organization of chromatin. | [
"14"
] | For instance, it has been shown that the participation of nuclear proteins in DPCLs induced by cisplatin can disturb the nuclear metabolism and the spatial organization of chromatin. | true | true | true | true | true | 1,782 |
2 | INTRODUCTION | 1 | 15 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | Also interestingly, the DPCLs (formed by antitumor trans-[PtCl2(E-iminoether)2]) inhibit DNA replication, DNA repair and are recognized by cellular components distinctly differently than plain Pt–DNA adducts (containing no proteins) (15). | [
"4",
"12",
"13",
"14",
"15"
] | 238 | 11,147 | 1 | false | Also interestingly, the DPCLs (formed by antitumor trans-[PtCl2(E-iminoether)2]) inhibit DNA replication, DNA repair and are recognized by cellular components distinctly differently than plain Pt–DNA adducts (containing no proteins). | [
"15"
] | Also interestingly, the DPCLs (formed by antitumor trans-[PtCl2(E-iminoether)2]) inhibit DNA replication, DNA repair and are recognized by cellular components distinctly differently than plain Pt–DNA adducts (containing no proteins). | true | true | true | true | true | 1,782 |
2 | INTRODUCTION | 1 | 4 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | In aggregate, DPCLs formed by cisplatin have not been so far studied as intensively as the adducts formed by this metallodrug only within DNA. | [
"4",
"12",
"13",
"14",
"15"
] | 142 | 11,148 | 0 | false | In aggregate, DPCLs formed by cisplatin have not been so far studied as intensively as the adducts formed by this metallodrug only within DNA. | [] | In aggregate, DPCLs formed by cisplatin have not been so far studied as intensively as the adducts formed by this metallodrug only within DNA. | true | true | true | true | true | 1,782 |
2 | INTRODUCTION | 1 | 4 | [
"B4",
"B12",
"B13",
"B14",
"B15"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | Hence, despite the biological significance of DPCLs, much remains to be learned about the mechanism of formation of these ternary complexes. | [
"4",
"12",
"13",
"14",
"15"
] | 140 | 11,149 | 0 | false | Hence, despite the biological significance of DPCLs, much remains to be learned about the mechanism of formation of these ternary complexes. | [] | Hence, despite the biological significance of DPCLs, much remains to be learned about the mechanism of formation of these ternary complexes. | true | true | true | true | true | 1,782 |
3 | INTRODUCTION | 1 | 16 | [
"B16"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | To further elucidate the nature of DNA–cisplatin–protein CLs, we have examined mechanism of the origin of these DPCLs and their cellular processing on molecular level. | [
"16"
] | 167 | 11,150 | 0 | false | To further elucidate the nature of DNA–cisplatin–protein CLs, we have examined mechanism of the origin of these DPCLs and their cellular processing on molecular level. | [] | To further elucidate the nature of DNA–cisplatin–protein CLs, we have examined mechanism of the origin of these DPCLs and their cellular processing on molecular level. | true | true | true | true | true | 1,783 |
3 | INTRODUCTION | 1 | 16 | [
"B16"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | A long-term goal of our studies in the field of platinum anticancer drugs is to contribute to the improvement of the structure–pharmacological relationship of platinum compounds. | [
"16"
] | 178 | 11,151 | 0 | false | A long-term goal of our studies in the field of platinum anticancer drugs is to contribute to the improvement of the structure–pharmacological relationship of platinum compounds. | [] | A long-term goal of our studies in the field of platinum anticancer drugs is to contribute to the improvement of the structure–pharmacological relationship of platinum compounds. | true | true | true | true | true | 1,783 |
3 | INTRODUCTION | 1 | 16 | [
"B16"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | Such studies also often employ comparisons between the effects of cisplatin and clinically ineffective trans analogue (trans-diamminedichloridoplatinum(II), transplatin) (Figure 1A) (16). | [
"16"
] | 187 | 11,152 | 1 | false | Such studies also often employ comparisons between the effects of cisplatin and clinically ineffective trans analogue (trans-diamminedichloridoplatinum(II), transplatin) (Figure 1A). | [
"16"
] | Such studies also often employ comparisons between the effects of cisplatin and clinically ineffective trans analogue (trans-diamminedichloridoplatinum(II), transplatin). | true | true | true | true | true | 1,783 |
3 | INTRODUCTION | 1 | 16 | [
"B16"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | Therefore, we also performed in parallel some studies aimed at the effects of transplatin. | [
"16"
] | 90 | 11,153 | 0 | false | Therefore, we also performed in parallel some studies aimed at the effects of transplatin. | [] | Therefore, we also performed in parallel some studies aimed at the effects of transplatin. | true | true | true | true | true | 1,783 |
0 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B34"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | In spite of the fact that the role of DNA adducts in the mechanism of antitumor effects of cisplatin and its analogues has been extensively examined, the significance of the DPCLs in which DNA and proteins are covalently linked by these platinum complexes has not been always fully appreciated. | [
"9",
"33",
"34"
] | 294 | 11,154 | 0 | false | In spite of the fact that the role of DNA adducts in the mechanism of antitumor effects of cisplatin and its analogues has been extensively examined, the significance of the DPCLs in which DNA and proteins are covalently linked by these platinum complexes has not been always fully appreciated. | [] | In spite of the fact that the role of DNA adducts in the mechanism of antitumor effects of cisplatin and its analogues has been extensively examined, the significance of the DPCLs in which DNA and proteins are covalently linked by these platinum complexes has not been always fully appreciated. | true | true | true | true | true | 1,784 |
0 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B34"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Hence, the mechanism of the origin of these DPCLs has not been so far investigated in such details as other (plain) DNA adducts of platinum compounds (containing no protein). | [
"9",
"33",
"34"
] | 174 | 11,155 | 0 | false | Hence, the mechanism of the origin of these DPCLs has not been so far investigated in such details as other (plain) DNA adducts of platinum compounds (containing no protein). | [] | Hence, the mechanism of the origin of these DPCLs has not been so far investigated in such details as other (plain) DNA adducts of platinum compounds (containing no protein). | true | true | true | true | true | 1,784 |
0 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B34"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | We show in this work that in cell-free media cisplatin forms DPCLs considerably more effectively than clinically ineffective transplatin (Figures 2 and 3 and Table 1). | [
"9",
"33",
"34"
] | 167 | 11,156 | 0 | false | We show in this work that in cell-free media cisplatin forms DPCLs considerably more effectively than clinically ineffective transplatin (Figures 2 and 3 and Table 1). | [] | We show in this work that in cell-free media cisplatin forms DPCLs considerably more effectively than clinically ineffective transplatin (Figures 2 and 3 and Table 1). | true | true | true | true | true | 1,784 |
0 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B34"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | It implies that there is a positive correlation between the efficiency of mononuclear bifunctional platinum complexes to form DPCLs and their antitumor effects. | [
"9",
"33",
"34"
] | 160 | 11,157 | 0 | false | It implies that there is a positive correlation between the efficiency of mononuclear bifunctional platinum complexes to form DPCLs and their antitumor effects. | [] | It implies that there is a positive correlation between the efficiency of mononuclear bifunctional platinum complexes to form DPCLs and their antitumor effects. | true | true | true | true | true | 1,784 |
0 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B34"
] | 17,329,374 | NA|pmid-12102553|pmid-3317449|pmid-11525387|pmid-12630848|NA|pmid-11098823|pmid-570092|pmid-2431763|pmid-10561728|pmid-15294448|pmid-11098823|pmid-2431763|pmid-2431763|pmid-6538808|pmid-1749377 | Thus, the results of the present work are consistent with previous findings demonstrating that DPCLs persist longer in cells exposed to cisplatin than in those exposed to the chemotherapeutically inactive trans analogue (9,33,34), which suggests relevance of such lesions to antitumor effects of cisplatin. | [
"9",
"33",
"34"
] | 306 | 11,158 | 0 | false | Thus, the results of the present work are consistent with previous findings demonstrating that DPCLs persist longer in cells exposed to cisplatin than in those exposed to the chemotherapeutically inactive trans analogue, which suggests relevance of such lesions to antitumor effects of cisplatin. | [
"9,33,34"
] | Thus, the results of the present work are consistent with previous findings demonstrating that DPCLs persist longer in cells exposed to cisplatin than in those exposed to the chemotherapeutically inactive trans analogue, which suggests relevance of such lesions to antitumor effects of cisplatin. | true | true | true | true | true | 1,784 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | In the present work, we paid attention to some aspects of the mechanism of the origin of the DPCLs by cisplatin, in particular to the mechanism of transformation of individual types of plain DNA adducts of cisplatin (and transplatin) into the DPCLs. | [
"35",
"36",
"37"
] | 249 | 11,159 | 0 | false | In the present work, we paid attention to some aspects of the mechanism of the origin of the DPCLs by cisplatin, in particular to the mechanism of transformation of individual types of plain DNA adducts of cisplatin (and transplatin) into the DPCLs. | [] | In the present work, we paid attention to some aspects of the mechanism of the origin of the DPCLs by cisplatin, in particular to the mechanism of transformation of individual types of plain DNA adducts of cisplatin (and transplatin) into the DPCLs. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | We assumed initially that the DPCLs may originate mostly from monofunctional adducts of cisplatin. | [
"35",
"36",
"37"
] | 98 | 11,160 | 0 | false | We assumed initially that the DPCLs may originate mostly from monofunctional adducts of cisplatin. | [] | We assumed initially that the DPCLs may originate mostly from monofunctional adducts of cisplatin. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | However, quite strikingly, the DPCLs also origin with a roughly identical efficiency by the transformation of DNA intrastrand CLs of cisplatin (Figure 4). | [
"35",
"36",
"37"
] | 154 | 11,161 | 0 | false | However, quite strikingly, the DPCLs also origin with a roughly identical efficiency by the transformation of DNA intrastrand CLs of cisplatin (Figure 4). | [] | However, quite strikingly, the DPCLs also origin with a roughly identical efficiency by the transformation of DNA intrastrand CLs of cisplatin (Figure 4). | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | In contrast, DNA interstrand CLs of cisplatin are markedly more stable in the presence of DNA-binding proteins than DNA intrastrand CLs of this metallodrug so that their transformation into DPCLs is markedly more difficult. | [
"35",
"36",
"37"
] | 223 | 11,162 | 0 | false | In contrast, DNA interstrand CLs of cisplatin are markedly more stable in the presence of DNA-binding proteins than DNA intrastrand CLs of this metallodrug so that their transformation into DPCLs is markedly more difficult. | [] | In contrast, DNA interstrand CLs of cisplatin are markedly more stable in the presence of DNA-binding proteins than DNA intrastrand CLs of this metallodrug so that their transformation into DPCLs is markedly more difficult. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | This observation may be associated with a rather severe conformational distortion induced in DNA by interstrand CLs of cisplatin (35,36). | [
"35",
"36",
"37"
] | 137 | 11,163 | 0 | false | This observation may be associated with a rather severe conformational distortion induced in DNA by interstrand CLs of cisplatin. | [
"35,36"
] | This observation may be associated with a rather severe conformational distortion induced in DNA by interstrand CLs of cisplatin. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 37 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | The interstrand CL is preferentially formed by cisplatin between opposite guanine residues in the 5′-GC/5′-GC sequence (37). | [
"35",
"36",
"37"
] | 124 | 11,164 | 1 | false | The interstrand CL is preferentially formed by cisplatin between opposite guanine residues in the 5′-GC/5′-GC sequence. | [
"37"
] | The interstrand CL is preferentially formed by cisplatin between opposite guanine residues in the 5′-GC/5′-GC sequence. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | The cross-linked guanine residues are not paired with hydrogen bonds to the complementary cytosines, which are located outside the duplex and not stacked with other aromatic rings. | [
"35",
"36",
"37"
] | 180 | 11,165 | 0 | false | The cross-linked guanine residues are not paired with hydrogen bonds to the complementary cytosines, which are located outside the duplex and not stacked with other aromatic rings. | [] | The cross-linked guanine residues are not paired with hydrogen bonds to the complementary cytosines, which are located outside the duplex and not stacked with other aromatic rings. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | All other base residues are paired, but distortion extends over at least 4 bp at the site of the CL. | [
"35",
"36",
"37"
] | 100 | 11,166 | 0 | false | All other base residues are paired, but distortion extends over at least 4 bp at the site of the CL. | [] | All other base residues are paired, but distortion extends over at least 4 bp at the site of the CL. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | In addition, the cis-diammineplatinum(II) bridge resides in the minor groove and the double helix is locally reversed to a left-handed, Z-DNA-like form. | [
"35",
"36",
"37"
] | 152 | 11,167 | 0 | false | In addition, the cis-diammineplatinum(II) bridge resides in the minor groove and the double helix is locally reversed to a left-handed, Z-DNA-like form. | [] | In addition, the cis-diammineplatinum(II) bridge resides in the minor groove and the double helix is locally reversed to a left-handed, Z-DNA-like form. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | This adduct induces the helix unwinding by 76–80° relative to B–DNA and also the bending of 20–40° of the helix axis at the cross-linked site toward the minor groove. | [
"35",
"36",
"37"
] | 166 | 11,168 | 0 | false | This adduct induces the helix unwinding by 76–80° relative to B–DNA and also the bending of 20–40° of the helix axis at the cross-linked site toward the minor groove. | [] | This adduct induces the helix unwinding by 76–80° relative to B–DNA and also the bending of 20–40° of the helix axis at the cross-linked site toward the minor groove. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | If the DPCL is formed from DNA adducts of cisplatin, it is necessary for DNA-binding protein to come into a very close contact with DNA at the site of the platinum adduct and to bind to DNA at this site relatively strongly. | [
"35",
"36",
"37"
] | 223 | 11,169 | 0 | false | If the DPCL is formed from DNA adducts of cisplatin, it is necessary for DNA-binding protein to come into a very close contact with DNA at the site of the platinum adduct and to bind to DNA at this site relatively strongly. | [] | If the DPCL is formed from DNA adducts of cisplatin, it is necessary for DNA-binding protein to come into a very close contact with DNA at the site of the platinum adduct and to bind to DNA at this site relatively strongly. | true | true | true | true | true | 1,785 |
1 | DISCUSSION | 1 | 35 | [
"B35",
"B36",
"B37"
] | 17,329,374 | pmid-8525382|pmid-10101191|pmid-2000402 | This may not be easily achieved in the case of DNA heavily distorted by the interstrand CL of cisplatin in contrast to other, less distorting, DNA adducts of this drug. | [
"35",
"36",
"37"
] | 168 | 11,170 | 0 | false | This may not be easily achieved in the case of DNA heavily distorted by the interstrand CL of cisplatin in contrast to other, less distorting, DNA adducts of this drug. | [] | This may not be easily achieved in the case of DNA heavily distorted by the interstrand CL of cisplatin in contrast to other, less distorting, DNA adducts of this drug. | true | true | true | true | true | 1,785 |
2 | DISCUSSION | 1 | 38 | [
"B38"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | It is also demonstrated in the present work that frequent monofunctional adducts of clinically ineffective transplatin are also transformed into DPCLs, but much less efficiently that intrastrand CLs or monofunctional adducts of cisplatin (Figure 4). | [
"38"
] | 249 | 11,171 | 0 | false | It is also demonstrated in the present work that frequent monofunctional adducts of clinically ineffective transplatin are also transformed into DPCLs, but much less efficiently that intrastrand CLs or monofunctional adducts of cisplatin (Figure 4). | [] | It is also demonstrated in the present work that frequent monofunctional adducts of clinically ineffective transplatin are also transformed into DPCLs, but much less efficiently that intrastrand CLs or monofunctional adducts of cisplatin (Figure 4). | true | true | true | true | true | 1,786 |
2 | DISCUSSION | 1 | 38 | [
"B38"
] | 17,329,374 | pmid-11525387|pmid-11749487|pmid-11406166|pmid-12119176|pmid-14602903|NA | This observation is consistent with the fact that in general monofunctional adducts of bifunctional transplatinum complexes undergo chelation reactions less readily than those of cisplatinum complexes (38). | [
"38"
] | 206 | 11,172 | 1 | false | This observation is consistent with the fact that in general monofunctional adducts of bifunctional transplatinum complexes undergo chelation reactions less readily than those of cisplatinum complexes. | [
"38"
] | This observation is consistent with the fact that in general monofunctional adducts of bifunctional transplatinum complexes undergo chelation reactions less readily than those of cisplatinum complexes. | true | true | true | true | true | 1,786 |
3 | DISCUSSION | 1 | 33 | [
"B33",
"B10",
"B39"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | It has been also demonstrated by others that the frequency of DPCLs in tumor cells treated with cisplatin is comparable with that of plain DNA interstrand CLs of this drug (33) or is even markedly higher (10). | [
"33",
"10",
"39"
] | 209 | 11,173 | 1 | false | It has been also demonstrated by others that the frequency of DPCLs in tumor cells treated with cisplatin is comparable with that of plain DNA interstrand CLs of this drug or is even markedly higher. | [
"33",
"10"
] | It has been also demonstrated by others that the frequency of DPCLs in tumor cells treated with cisplatin is comparable with that of plain DNA interstrand CLs of this drug or is even markedly higher. | true | true | true | true | true | 1,787 |
3 | DISCUSSION | 1 | 39 | [
"B33",
"B10",
"B39"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | Thus, considering the bulky nature of DPCLs it is likely that these lesions formed by cisplatin represent a more distinct and persisting structural motif recognized by the components of downstream cellular systems processing DNA damage considerably differently than the plain DNA adducts of this metallodrug (39). | [
"33",
"10",
"39"
] | 313 | 11,174 | 1 | false | Thus, considering the bulky nature of DPCLs it is likely that these lesions formed by cisplatin represent a more distinct and persisting structural motif recognized by the components of downstream cellular systems processing DNA damage considerably differently than the plain DNA adducts of this metallodrug. | [
"39"
] | Thus, considering the bulky nature of DPCLs it is likely that these lesions formed by cisplatin represent a more distinct and persisting structural motif recognized by the components of downstream cellular systems processing DNA damage considerably differently than the plain DNA adducts of this metallodrug. | true | true | true | true | true | 1,787 |
3 | DISCUSSION | 1 | 33 | [
"B33",
"B10",
"B39"
] | 17,329,374 | pmid-2204440|pmid-6538808|pmid-10561728|NA | This conclusion is corroborated by the results of the present work (Figures 5 and 6) demonstrating that DPCLs linked by cisplatin inhibit DNA polymerization or removal of major cisplatin adducts from DNA by NER systems much more efficiently than the plain DNA adducts (not linked to proteins). | [
"33",
"10",
"39"
] | 293 | 11,175 | 0 | false | This conclusion is corroborated by the results of the present work (Figures 5 and 6) demonstrating that DPCLs linked by cisplatin inhibit DNA polymerization or removal of major cisplatin adducts from DNA by NER systems much more efficiently than the plain DNA adducts (not linked to proteins). | [] | This conclusion is corroborated by the results of the present work (Figures 5 and 6) demonstrating that DPCLs linked by cisplatin inhibit DNA polymerization or removal of major cisplatin adducts from DNA by NER systems much more efficiently than the plain DNA adducts (not linked to proteins). | true | true | true | true | true | 1,787 |
4 | DISCUSSION | 1 | 15 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | Our observation (Figure 6) that the mammalian NER system did not remove proteins cross-linked to DNA at a detectable level deserves further discussion. | [
"15",
"40",
"40"
] | 151 | 11,176 | 0 | false | Our observation (Figure 6) that the mammalian NER system did not remove proteins cross-linked to DNA at a detectable level deserves further discussion. | [] | Our observation (Figure 6) that the mammalian NER system did not remove proteins cross-linked to DNA at a detectable level deserves further discussion. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 15 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | This phenomenon was first observed by us 3 years ago (15). | [
"15",
"40",
"40"
] | 58 | 11,177 | 1 | false | This phenomenon was first observed by us 3 years ago. | [
"15"
] | This phenomenon was first observed by us 3 years ago. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 15 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | We investigated in this recent work excision by mammalian repair systems of the DNA–protein CL formed by another antitumor platinum drug, trans-[PtCl2(E-iminoether)2], between 148 bp DNA fragment and 20 kDa histone H1 and found that such bulky DNA–protein CLs were not removed. | [
"15",
"40",
"40"
] | 277 | 11,178 | 0 | false | We investigated in this recent work excision by mammalian repair systems of the DNA–protein CL formed by another antitumor platinum drug, trans-[PtCl2(E-iminoether)2], between 148 bp DNA fragment and 20 kDa histone H1 and found that such bulky DNA–protein CLs were not removed. | [] | We investigated in this recent work excision by mammalian repair systems of the DNA–protein CL formed by another antitumor platinum drug, trans-[PtCl2(E-iminoether)2], between 148 bp DNA fragment and 20 kDa histone H1 and found that such bulky DNA–protein CLs were not removed. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 40 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | Quite recently, our earlier results have been confirmed by others (40) demonstrating that the human NER system did not remove other, also bulky 16 kDa protein (T4 pyrimidine dimer glycosylase) cross-linked to DNA. | [
"15",
"40",
"40"
] | 213 | 11,179 | 1 | false | Quite recently, our earlier results have been confirmed by others demonstrating that the human NER system did not remove other, also bulky 16 kDa protein (T4 pyrimidine dimer glycosylase) cross-linked to DNA. | [
"40"
] | Quite recently, our earlier results have been confirmed by others demonstrating that the human NER system did not remove other, also bulky 16 kDa protein cross-linked to DNA. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 40 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | It has been also suggested (40) that the failure to remove DNA–bulky protein CLs is due to the steric hindrance caused by the size of the cross-linked protein that may interfere sterically with the assembly of the mammalian excision system. | [
"15",
"40",
"40"
] | 240 | 11,180 | 1 | false | It has been also suggested that the failure to remove DNA–bulky protein CLs is due to the steric hindrance caused by the size of the cross-linked protein that may interfere sterically with the assembly of the mammalian excision system. | [
"40"
] | It has been also suggested that the failure to remove DNA–bulky protein CLs is due to the steric hindrance caused by the size of the cross-linked protein that may interfere sterically with the assembly of the mammalian excision system. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 15 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | Thus, our results demonstrating failure of the mammalian NER system to remove the DNA–Pt–protein CLs reinforce the view that DNA–protein CLs formed by platinum drugs may be among the critical lesions relevant to their antitumor effects. | [
"15",
"40",
"40"
] | 236 | 11,181 | 0 | false | Thus, our results demonstrating failure of the mammalian NER system to remove the DNA–Pt–protein CLs reinforce the view that DNA–protein CLs formed by platinum drugs may be among the critical lesions relevant to their antitumor effects. | [] | Thus, our results demonstrating failure of the mammalian NER system to remove the DNA–Pt–protein CLs reinforce the view that DNA–protein CLs formed by platinum drugs may be among the critical lesions relevant to their antitumor effects. | true | true | true | true | true | 1,788 |
4 | DISCUSSION | 1 | 15 | [
"B15",
"B40",
"B40"
] | 17,329,374 | pmid-14602903|pmid-16537484|pmid-16537484 | Other proteins known to specifically bind to cisplatin–DNA lesions and proteins involved in damage recognition and repair signaling will be used in our future research to obtain more details on processing DNA damage by cisplatin in vivo. | [
"15",
"40",
"40"
] | 237 | 11,182 | 0 | false | Other proteins known to specifically bind to cisplatin–DNA lesions and proteins involved in damage recognition and repair signaling will be used in our future research to obtain more details on processing DNA damage by cisplatin in vivo. | [] | Other proteins known to specifically bind to cisplatin–DNA lesions and proteins involved in damage recognition and repair signaling will be used in our future research to obtain more details on processing DNA damage by cisplatin in vivo. | true | true | true | true | true | 1,788 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | The results of the present work also demonstrate that in cell-free media transplatin forms less DPCLs than cisplatin (Figures 2 and 3). | [
"9",
"33",
"41"
] | 135 | 11,183 | 0 | false | The results of the present work also demonstrate that in cell-free media transplatin forms less DPCLs than cisplatin (Figures 2 and 3). | [] | The results of the present work also demonstrate that in cell-free media transplatin forms less DPCLs than cisplatin (Figures 2 and 3). | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | This result may seem to contradict conclusions published earlier by others according to which transplatin forms considerably more DPCLs than cisplatin (9,33). | [
"9",
"33",
"41"
] | 158 | 11,184 | 0 | false | This result may seem to contradict conclusions published earlier by others according to which transplatin forms considerably more DPCLs than cisplatin. | [
"9,33"
] | This result may seem to contradict conclusions published earlier by others according to which transplatin forms considerably more DPCLs than cisplatin. | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | However, these earlier conclusions have been drawn on the basis of the results obtained with the cells treated with equitoxic doses of cisplatin and transplatin, demonstrating a much higher molar concentration for transplatin. | [
"9",
"33",
"41"
] | 226 | 11,185 | 0 | false | However, these earlier conclusions have been drawn on the basis of the results obtained with the cells treated with equitoxic doses of cisplatin and transplatin, demonstrating a much higher molar concentration for transplatin. | [] | However, these earlier conclusions have been drawn on the basis of the results obtained with the cells treated with equitoxic doses of cisplatin and transplatin, demonstrating a much higher molar concentration for transplatin. | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | Thus, if these results are normalized to the identical level of DNA platination, then in accordance with the results of the present work transplatin is much less effective agent capable of forming DPCLs than cisplatin. | [
"9",
"33",
"41"
] | 218 | 11,186 | 0 | false | Thus, if these results are normalized to the identical level of DNA platination, then in accordance with the results of the present work transplatin is much less effective agent capable of forming DPCLs than cisplatin. | [] | Thus, if these results are normalized to the identical level of DNA platination, then in accordance with the results of the present work transplatin is much less effective agent capable of forming DPCLs than cisplatin. | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 41 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | It is generally assumed that cytotoxic DNA adduct of antitumor drug has to be fairly persistent (41). | [
"9",
"33",
"41"
] | 101 | 11,187 | 1 | false | It is generally assumed that cytotoxic DNA adduct of antitumor drug has to be fairly persistent. | [
"41"
] | It is generally assumed that cytotoxic DNA adduct of antitumor drug has to be fairly persistent. | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | Among DNA adducts of cisplatin this requirement is very well accomplished by DPCLs. | [
"9",
"33",
"41"
] | 83 | 11,188 | 0 | false | Among DNA adducts of cisplatin this requirement is very well accomplished by DPCLs. | [] | Among DNA adducts of cisplatin this requirement is very well accomplished by DPCLs. | true | true | true | true | true | 1,789 |
5 | DISCUSSION | 1 | 9 | [
"B9",
"B33",
"B41"
] | 17,329,374 | pmid-2431763|pmid-6538808|pmid-3552211 | Hence, a further systematic and detailed analysis of the efficiency of cisplatin and other antitumor platinum compounds to form DPCLs in cells and the role of these lesions in the mechanism underlying antitumor effects of platinum drugs is urgently needed. | [
"9",
"33",
"41"
] | 256 | 11,189 | 0 | false | Hence, a further systematic and detailed analysis of the efficiency of cisplatin and other antitumor platinum compounds to form DPCLs in cells and the role of these lesions in the mechanism underlying antitumor effects of platinum drugs is urgently needed. | [] | Hence, a further systematic and detailed analysis of the efficiency of cisplatin and other antitumor platinum compounds to form DPCLs in cells and the role of these lesions in the mechanism underlying antitumor effects of platinum drugs is urgently needed. | true | true | true | true | true | 1,789 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43"
] | 17,329,374 | NA|pmid-15196020 | There are several reactive agents which produce CLs between DNA and proteins in van der Waals’ contact. | [
"42",
"43"
] | 103 | 11,190 | 0 | false | There are several reactive agents which produce CLs between DNA and proteins in van der Waals’ contact. | [] | There are several reactive agents which produce CLs between DNA and proteins in van der Waals’ contact. | true | true | true | true | true | 1,790 |
6 | DISCUSSION | 1 | 42 | [
"B42",
"B43"
] | 17,329,374 | NA|pmid-15196020 | Thus, the cross-linking procedures involving these agents provide a tool for identification of proteins or protein domains closely positioned to DNA including mapping of protein-binding sites on DNA in vivo (42). | [
"42",
"43"
] | 212 | 11,191 | 1 | false | Thus, the cross-linking procedures involving these agents provide a tool for identification of proteins or protein domains closely positioned to DNA including mapping of protein-binding sites on DNA in vivo. | [
"42"
] | Thus, the cross-linking procedures involving these agents provide a tool for identification of proteins or protein domains closely positioned to DNA including mapping of protein-binding sites on DNA in vivo. | true | true | true | true | true | 1,790 |
6 | DISCUSSION | 1 | 43 | [
"B42",
"B43"
] | 17,329,374 | NA|pmid-15196020 | The results of the present work support the view that cross-linking DNA and proteins by platinum complexes can be also applied to studies of specific protein–DNA interactions both in vitro and in vivo (43). | [
"42",
"43"
] | 206 | 11,192 | 1 | false | The results of the present work support the view that cross-linking DNA and proteins by platinum complexes can be also applied to studies of specific protein–DNA interactions both in vitro and in vivo. | [
"43"
] | The results of the present work support the view that cross-linking DNA and proteins by platinum complexes can be also applied to studies of specific protein–DNA interactions both in vitro and in vivo. | true | true | true | true | true | 1,790 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | The mechanisms and regulation of gene expression in the Archaea have been studied during the past 25 years [reviewed in (1)]. | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 125 | 11,193 | 0 | false | The mechanisms and regulation of gene expression in the Archaea have been studied during the past 25 years. | [
"reviewed in (1)"
] | The mechanisms and regulation of gene expression in the Archaea have been studied during the past 25 years. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | However, our knowledge on them remains modest in comparison to what is known on transcription in the other two domains of life, the Eukarya and Bacteria. | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 153 | 11,194 | 0 | false | However, our knowledge on them remains modest in comparison to what is known on transcription in the other two domains of life, the Eukarya and Bacteria. | [] | However, our knowledge on them remains modest in comparison to what is known on transcription in the other two domains of life, the Eukarya and Bacteria. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | Initial studies revealed that the archaeal basal transcription machinery resembles the core components of the eukaryal RNA polymerase (RNA Pol) II apparatus (2–7). | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 163 | 11,195 | 0 | false | Initial studies revealed that the archaeal basal transcription machinery resembles the core components of the eukaryal RNA polymerase (RNA Pol) II apparatus. | [
"2–7"
] | Initial studies revealed that the archaeal basal transcription machinery resembles the core components of the eukaryal RNA polymerase (RNA Pol) II apparatus. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | Through the establishment of in vitro transcription systems for some archaea (8–13), it became possible to identify the archaeal factors necessary for specific initiation of transcription. | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 188 | 11,196 | 0 | false | Through the establishment of in vitro transcription systems for some archaea, it became possible to identify the archaeal factors necessary for specific initiation of transcription. | [
"8–13"
] | Through the establishment of in vitro transcription systems for some archaea, it became possible to identify the archaeal factors necessary for specific initiation of transcription. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | Consisting of only the TATA-binding protein (TBP), transcription factor B (TFB), homologous to the eukaryotic TFIIB, and the RNA polymerase, a multi-subunit enzyme, the minimal archaeal transcription pre-initiation complex appears to be a simplified version of the eukaryotic RNA Pol II system. | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 294 | 11,197 | 0 | false | Consisting of only the TATA-binding protein (TBP), transcription factor B (TFB), homologous to the eukaryotic TFIIB, and the RNA polymerase, a multi-subunit enzyme, the minimal archaeal transcription pre-initiation complex appears to be a simplified version of the eukaryotic RNA Pol II system. | [] | Consisting of only the TATA-binding protein (TBP), transcription factor B (TFB), homologous to the eukaryotic TFIIB, and the RNA polymerase, a multi-subunit enzyme, the minimal archaeal transcription pre-initiation complex appears to be a simplified version of the eukaryotic RNA Pol II system. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | With the ongoing genome sequencing projects many transcription regulators could be identified in archaeal genomes. | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 114 | 11,198 | 0 | false | With the ongoing genome sequencing projects many transcription regulators could be identified in archaeal genomes. | [] | With the ongoing genome sequencing projects many transcription regulators could be identified in archaeal genomes. | true | true | true | true | true | 1,791 |
0 | INTRODUCTION | 1 | 1 | [
"b1",
"b2",
"b7",
"b8",
"b13",
"b14",
"b15",
"b16",
"b17",
"b18",
"b19",
"b20",
"b21",
"b22",
"b23"
] | 16,973,899 | pmid-11282478|pmid-7597027|pmid-380989|pmid-10400604|pmid-9184236|pmid-10556324|pmid-12675791|pmid-12692306|pmid-16230629|pmid-10635322|pmid-10973967|pmid-11809882|pmid-10900210|pmid-10049378|pmid-12381724 | Surprisingly, many of them were homologs to the members of the bacterial Lrp-like regulator family (14,15). | [
"1",
"2",
"7",
"8",
"13",
"14",
"15",
"16",
"17",
"18",
"19",
"20",
"21",
"22",
"23"
] | 107 | 11,199 | 0 | false | Surprisingly, many of them were homologs to the members of the bacterial Lrp-like regulator family. | [
"14,15"
] | Surprisingly, many of them were homologs to the members of the bacterial Lrp-like regulator family. | true | true | true | true | true | 1,791 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.